CDH
GSK icon

Charles D. Hyman’s GSK GSK Stock Holding History

Charles D. Hyman’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-4,160
Closed -$244K – 200
2019
Q4 		$244K Sell
4,160
-240
-5% -$13.3K 0.02% 184
2019
Q3 		$235K Hold
4,400
– – 0.02% 172
2019
Q2 		$220K Buy
+4,400
New +$221K 0.02% 177

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Charles D. Hyman's GSK Position: Q1 2020 in Review

Charles D. Hyman sold out of GSK (GSK) in Q1 2020, closing a stake of 4,160 shares — an estimated $244K sold.

Charles D. Hyman first reported a position in GSK in Q2 2019 and held it in 3 quarters. The position peaked at $244K in Q4 2019. 817 funds tracked by Wall St. Rank hold GSK as of Q1 2020.

  • Charles D. Hyman reported no remaining GSK position as of Q1 2020 after selling out during the quarter.
  • Charles D. Hyman sold 4,160 GSK shares in Q1 2020, an estimated $244K.
  • Charles D. Hyman first reported a position in GSK in Q2 2019 and held it in 3 quarters.
  • Charles D. Hyman's GSK position peaked at $244K in Q4 2019.
  • 817 funds tracked by Wall St. Rank held GSK as of Q1 2020.

Based on Charles D. Hyman's 13F filing for Q1 2020, filed 30 Apr 2020.